Elevated adipose and liver IRAP/oxytocinase activity may account for increased oxytocin degradation in obesity. Effect of IRAP blockade on obese phenotype: S1-A9


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles